Health News Releases

July 11, 17:15

Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research

Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced a groundbreaking study (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3

July 11, 10:50

Newly Elected Directors of Sinovac Hold the First Board Meeting

Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprisin

July 11, 10:20

Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technolo

July 10, 14:40

Rigaku Announces STAvesta, a Thermal Analyzer Tailor-made for Next-generation Material Development

Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has launched worldwide sales of STAvesta, a thermal analyzer

July 09, 11:35

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts - early

July 09, 10:45

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial

Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company see

July 08, 15:10

CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology

CorFlow Therapeutics AG (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.corflow.com&esheet=54285516&newsitemid=20250707156114&lan=en-US&anchor=CorFlow+Therapeutics+AG&index=1&md5

July 04, 10:00

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost

July 02, 17:08

Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta

Follitropin delta starting dose of 15 micrograms (µg)/day has comparable efficacy and safety as a starting dose of 225 International Units (IU)/day of follitropin alfa for ovarian stimulation in vitro

July 01, 14:13

Galderma Announces Departure of Its Chief Financial Officer

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive o

July 01, 14:10

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin infusion (hu

June 29, 14:10

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction ass

June 27, 14:20

Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare

Six leading international organizations representing patients, physicians, pharmacists, nurses, hospitals, and the pharmaceutical industry have today adopted the first joint ethical principle in the h

June 27, 13:45

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

In a significant showcase for investors, BeOne Medicines Ltd. (https://beonemedicines.com/) (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will announce major advancements to its

June 27, 11:20

IFF’s 2024 Do More Good Report Highlights Progress in Sustainability and Innovation

IFF (https://www.iff.com/) (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health, and biosciences—has released its 2024 Do More Good Report (https://www.iff.com/sustainabilityre

June 27, 10:20

MEDIPEAU Inc Showcases “BARRICURE” Medical Device Brand for Damaged Skin at Malaysia’s ‘Immunodermatology Updates 2025’ Symposium

On June 23, 2025, the ‘Immunodermatology Updates 2025’ symposium was held in Malaysia. At this event, CHAYA AND LIGHT SDN. BHD., the official Malaysian distribution partner of MEDIPEAU Inc., introduce

June 26, 11:00

Parse Biosciences GigaLab to Support Mount Sinai Researchers in Generating One of the Largest Alzheimer’s and Parkinson’s Single Cell Datasets

Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on understandin

June 25, 16:20

Takeda Announces New Assignments of Directors

Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today. Taked

June 25, 15:00

Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients li

June 24, 16:20

Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired

June 24, 13:30

Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges

As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper exa

June 19, 15:00

India to Host Inaugural World Technology Summit in 2025

World Technology (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.worldtechnology.games&esheet=54277017&newsitemid=20250616197549&lan=en-US&anchor=World+Technology&index=1&md5=b2

June 19, 14:00

SAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the Board

SAIF Partners IV L.P., (“SAIF Partners”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”), beneficially owning approximately 15% of the outstanding common shares, toda

June 19, 10:15

LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials

Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay.

June 19, 08:42

SINOVAC Announces New Board Member

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a resignation notice from David Guowei Wang

News by Region

News by Industry